DiaMedica Therapeutics DMAC
NASDAQ DMAC
$8.23 -0.12 (-1.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

DiaMedica Therapeutics (DMAC) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

DiaMedica Therapeutics' Return on Capital Employed [ROCE] was -92.41% in Q2 2026, up 8.94 percentage points from -101.35% a year earlier but down 21.05 percentage points from the prior quarter.

Analysis

DiaMedica Therapeutics (DMAC) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at DiaMedica Therapeutics came in at -70.59%, down 11.12 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has now declined for three consecutive years, though with a five-year change of +6.16 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -59.47% in FY2024 (-8.22 pp), -51.26% in FY2023 (-14.22 pp), -37.03% in FY2022 (+1.62 pp) and -38.66% in FY2021 (+38.09 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -101.35% (Q2 2025) and -29.94% (Q4 2021) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in two of the last eight quarters, with an average year-over-year change of -18.96 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q2 2022 (a gain of 32.78 percentage points); the worst was Q2 2025 (a drop of 56.53 percentage points).
  • Per Business Quant data, DMAC's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -71.36% (Q1 2026), -63.61% (Q4 2025) and -86.18% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 DiaMedica Therapeutics 443.81 Mn 443.81 Mn - -92.41%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -92.41%
Mar 31, 2026 -71.36%
Dec 31, 2025 -63.61%
Sep 30, 2025 -86.18%
Jun 30, 2025 -101.35%
Mar 31, 2025 -76.69%
Dec 31, 2024 -60.58%
Sep 30, 2024 -47.87%
Jun 30, 2024 -44.82%
Mar 31, 2024 -43.77%
Dec 31, 2023 -39.85%
Sep 30, 2023 -33.48%
Jun 30, 2023 -39.29%
Mar 31, 2023 -54.20%
Dec 31, 2022 -41.73%
Sep 30, 2022 -36.26%
Jun 30, 2022 -34.60%
Mar 31, 2022 -31.95%
Dec 31, 2021 -29.94%
Sep 30, 2021 -43.66%
API Access

DiaMedica Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DMAC&period=max&api_key=YOUR_API_KEY